Efficacy and safety of different dosages of rituximab for refractory generalized AChR myasthenia gravis: A meta-analysis
Ting Li, Guo-Qian Zhang, Yue Li, Shu-An Dong, Nan Wang, Ming Yi, Yuan Qi, Hui Zhai, Li Yang, Fu‐Dong Shi, Chun‐Sheng Yang
Topics & Concepts
MedicineRituximabMyasthenia gravisRefractory (planetary science)Meta-analysisDoseInternal medicineOncologyLymphomaAstrobiologyPhysicsMyasthenia Gravis and ThymomaAdrenal Hormones and DisordersAutoimmune Neurological Disorders and Treatments